The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI descriptionJohn McGonigle, Anna Murphy, Louise M. Paterson et al.|Journal of Psychopharmacology|2016Cited by 21